Aqil Farrukh (62 results)

Condition: As New. Unread book in perfect condition.

Condition: New.

Condition: New.

Hardback. Condition: New.

Condition: New.

Condition: New. In English.

Condition: As New. Unread book in perfect condition.

Taschenbuch. Condition: Neu. Biological activities of certain Indian medicinal plants | Extracts with therapeutic potential | Farrukh Aqil (u. a.) | Taschenbuch | 256 S. | Englisch | 2010 | LAP LAMBERT Academic Publishing | EAN 9783838340692 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu.…

Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Hardback. Condition: New.

Rilegato in Tela. Condition: fine. English Text.Oxford, 2008; clothbound, pp. 304, cm 18x24. Libro.

Paperback. Condition: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Condition: Good. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Ex-library, so some stamps and wear, but in good overall condition. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions.…

Condition: New.

Hardcover. Condition: new. Hardcover. This book offers an in-depth exploration of the latest advances in cancer therapeutics, with a strong focus on innovative drug strategies and molecular breakthroughs that are shaping the future of oncology. It explores a broad range of modern treatment approaches, including immunotherapy, targeted therapies, epigenetic modulators, and next-generation drug delivery systems.The chapters explore a wide range of topics including small molecule inhibitors, monoclonal antibodies, nanotechnology-based interventions, and emerging tools like CRISPR and AI-driven drug discovery. A key strength of the book is its integration of scientific innovation with clinical translation and regulatory considerations, offering both depth and practical relevance.By bridging the gap between research and real-world application, this book provides a forward-looking roadmap for the future of cancer care. It is an essential resource for oncologists, biomedical researchers, pharmaceutical professionals, and post-graduate students seeking a clear and up-to-date understanding of current and next-generation cancer treatments. This book offers an in-depth exploration of the latest advances in cancer therapeutics, with a strong focus on innovative drug strategies and molecular breakthroughs that are shaping the future of oncology. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

Condition: New.

Condition: As New. Unread book in perfect condition.

Taschenbuch. Condition: Neu. Combating Fungal Infections | Problems and Remedy | Iqbal Ahmad (u. a.) | Taschenbuch | xx | Englisch | 2014 | Springer | EAN 9783642446726 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. …

Condition: New.

Condition: New.

Condition: New. In English.

Gebunden. Condition: New. .Primariliy, this book is dedicated, but also highly recommended, to students, teachers and researchers enganged in universities, R&D insitutions, pharmaceutical or herbal industry, as well as health organizations. Advances in Food Sciences, 07/2007| Die.

Condition: Very Good.

Condition: As New. Unread book in perfect condition.

Buch. Condition: Neu. Neuware -This timely and original handbook paves the way to success in plant-based drug development, systematically addressing the issues facing a pharmaceutical scientist who wants to turn a plant compound into a safe and effective drug. Plant pharmacologists from around the world demonstrate the potentials and pitfalls involved, with many of the studies and experiments reported here published for the first time. The result is a valuable source of information unavailable elsewhere. 384 pp. Englisch.…

Buch. Condition: Neu. Neuware -This timely and original handbook paves the way to success in plant-based drug development, systematically addressing the issues facing a pharmaceutical scientist who wants to turn a plant compound into a safe and effective drug. Plant pharmacologists from around the world demonstrate the potentials and pitfalls involved, with many of the studies and experiments reported here published for the first time. The result is a valuable source of information unavailable elsewhere. 384 pp. Englisch.…

Condition: New. In English.

Condition: As New. Unread book in perfect condition.

Condition: New. In English.

Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Fungi are eukaryotic microorganisms that are closely related to humans at cellular level. Human fungal pathogens belong to various classes of fungi, mainly zygo- cetes, ascomycetes, basidiomycetes, and deuteromycetes. In recent years, fungal infections have dramatically increased as a result of improved diagnosis, high frequency of catheterization, instrumentation, etc. However, the main cause remains the increasing number of immunosuppressed patients, mostly because of HIV infection and indiscriminate usage of antineoplastic and immunosuppressive agents, broad-spectrum antibiotics and prosthetic devices, and grafts in clinical settings. Presently available means of combating fungal infections are still weak and clumsy compared to control of bacterial infection. The present scenario of antifungal therapy is still based on two classes of antifungal drugs (polyenes and azoles). These drugs are effective in many cases, but display toxicity and limited spectrum of ef cacy. The recent trend towards emergence of drug-resistant isolates in the clinic is an additional problem. In recent years, a few new antifungal drugs have entered the clinics, but they are expected to undergo same fate as the older antifungal drugs. The application of fungal genomics offers an unparalleled opportunity to develop novel antifungal drugs. However, it is too early to expect any novel drugs, as the antifungal drug discovery program is in the stage of infancy. Interestingly, several novel antifungal drug targets have been identi ed and validated. …